| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
Revenue  | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Expenses | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 4 | 0 | 0 | 0 |
| EBITDA | 0 | -0 | 0 | 0 | -0 | -0 | -0 | -4 | -0 | -0 | 0 |
| Operating Profit % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | -0 | 0 | -4 | -0 | -0 | -0 | -4 | -0 | -0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | -0 | 0 | -4 | -0 | -0 | -0 | -4 | -0 | -0 | 0 |
| EPS in ₹ | -0.05 | -0.11 | 0.00 | -6.37 | -0.58 | -0.54 | -0.41 | -6.55 | -0.17 | -0.10 | 0.60 |
Bacil Pharma
36.59
+0.71
(1.98%)
Market Cap
21.52 Cr
EPS
-0.10
PE Ratio
60.81
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
62.56
52 Week low
12.03
PB Ratio
20.08
Debt to Equity
0.05
Sector
Pharmaceuticals
Live Chart 
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
| 1,683.45 | 4,03,916.05 | 34.10 | 49,887.20 | 12.06 | 9,648 | 13.77 | 52.67 | |
| 5,620.45 | 1,49,205.29 | 72.77 | 8,184.00 | 0.89 | 1,600 | 64.53 | 45.57 | |
| 1,461.90 | 1,18,065.10 | 23.53 | 26,520.70 | 14.17 | 4,155 | 47.38 | 52.92 | |
| 3,056.05 | 1,03,430.62 | 56.27 | 10,785.70 | 11.59 | 1,656 | 13.54 | 47.23 | |
| 1,107.95 | 92,448.55 | 17.17 | 28,905.40 | 12.36 | 5,578 | 1.69 | 30.37 | |
| 2,201.15 | 90,812.16 | 43.84 | 10,615.60 | 19.57 | 1,942 | -16.38 | 35.15 | |
| 1,968.45 | 89,800.21 | 31.28 | 20,141.50 | 19.94 | 1,936 | 38.82 | 43.62 | |
| 883.10 | 88,860.52 | 19.73 | 19,831.50 | 13.82 | 3,831 | 29.92 | 40.81 | |
| 1,094.75 | 63,583.26 | 18.24 | 29,559.20 | 17.55 | 3,169 | -10.04 | 43.94 | |
| 29,597.00 | 62,891.56 | 47.49 | 6,097.20 | 10.80 | 1,201 | 16.01 | 49.75 |
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
100.00 %
ROE
-47.46 %
ROCE
-47.57 %
EBITDA Margin (Avg.)
-49.54 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 7 | 7 | 7 | 5 | 5 | 4 | 4 | 1 | 1 | 1 |
| Fixed Assets | 0 | 5 | 6 | 3 | 3 | 3 | 3 | 0 | 0 | 0 |
| Current Assets | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| Other Assets | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Total Liabilities | 7 | 7 | 7 | 5 | 5 | 4 | 4 | 1 | 1 | 1 |
| Current Liabilities | 0 | 0 | 0 | 3 | 3 | 3 | 3 | 0 | 0 | 0 |
| Non Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 7 | 6 | 6 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Reserve & Surplus | -0 | -0 | -0 | -4 | -5 | -5 | -5 | -5 | -5 | -5 |
| Share Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | -0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | -0 | 0 |
| Investing Activities | -0 | -0 | 0 | -1 | 0 | 0 | 1 | 4 | -0 | 0 |
| Operating Activities | 0 | 0 | 0 | 1 | -0 | -0 | -0 | -4 | -0 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | -0 | -0 | -0 | 0 | 0 | -0 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
| Promoter | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 20.70 % | 10.60 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 51.38 % | 53.85 % | 53.88 % | 52.88 % | 52.83 % | 52.90 % | 53.74 % | 53.77 % | 53.76 % | 53.79 % | 53.80 % | 53.77 % | 53.89 % | 53.91 % | 59.61 % | 67.42 % |
| Others | 5.95 % | 3.48 % | 3.45 % | 4.45 % | 4.50 % | 4.43 % | 3.59 % | 3.56 % | 3.57 % | 3.54 % | 3.53 % | 3.56 % | 3.44 % | 3.42 % | 19.69 % | 21.98 % |
| No of Share Holders | 0 | 6,410 | 6,319 | 6,461 | 6,514 | 6,532 | 6,545 | 6,548 | 6,649 | 6,663 | 6,647 | 6,628 | 6,770 | 6,794 | 6,902 | 7,461 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
No dividends have been distributed by the company in the past 10 years
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
Announcement under Regulation 30 (LODR)-Allotment
Board Meeting Outcome for Outcome Of The Preferential Allotment Committee (The Committee) Held On 12Th
March 2025 For Allotment Of 6580500 Equity Shares To Non-Promoters On A Preferential Basis
Pursuant To Share Swap
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
In-Principle Approval Granted By Stock Exchange
In-Principle Approval Granted By Stock Exchange
Integrated Filing (Financial)
Announcement under Regulation 30 (LODR)-Resignation of Director
Announcement under Regulation 30 (LODR)-Resignation of Director
Announcement under Regulation 30 (LODR)-Newspaper Publication
Outcome Of Board Meeting
Board Meeting Outcome for Outcome Of Board Meeting
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Board Meeting Intimation for 1) To Consider And Approve The Un-Audited Financial Results Along With Limited Review Report Of The Company For The Quarter Ended 31St December 2024.
2) Other Routine Bus
Closure of Trading Window
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Shareholder Meeting / Postal Ballot-Scrutinizers Report
Shareholder Meeting / Postal Ballot-Outcome of EGM
Corrigendum To The Notice Of The EOGM Dated 15/10/2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
EXTRA-ORDINARY GENERAL MEETING ('EOGM') OF THE MEMBERS OF BACIL PHARMA LIMITED WILL BE HELD ON THURSDAY, NOVEMBER 14, 2024 AT 11:00 AM THROUGH VIDEO CONFERENCING ('VC')/OTHER AUDIO VISUAL MEANS ('OAVM')
Outcome Of Board Meeting Held On 23Rd October 2024
Board Meeting Outcome for Outcome Of Board Meeting
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Board Meeting Intimation for To Be Held On Wednesday, 23Rd October, 2024
Revised Outcome Of Board Meeting
Outcome Of Board Meeting
Announcement under Regulation 30 (LODR)-Acquisition
Board Meeting Outcome for Board Meeting Outcome
Board Meeting Intimation for Meeting To Be Held On 15.10.2024
Announcement under Regulation 30 (LODR)-Change in Registered Office Address
Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON 27TH SEPTEMBER, 2024
Submission Of Voting Result For Annual General Meeting Held On 27Th September,2024.
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Closure of Trading Window
Announcement under Regulation 30 (LODR)-Cessation
Shareholder Meeting / Postal Ballot-Outcome of AGM
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Board Meeting Intimation for Board Meeting To Be Held On Friday, 27Th September, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Announcement under Regulation 30 (LODR)-Newspaper Publication
Notice Of The Annual General Meeting Of The Company
Reg. 34 (1) Annual Report.
Technical Indicators
RSI(14)
Neutral 31.98
ATR(14)
Less Volatile 1.29
STOCH(9,6)
Oversold 9.51
STOCH RSI(14)
Oversold 19.36
MACD(12,26)
Bearish -0.42
ADX(14)
Strong Trend 36.88
UO(9)
Bearish 33.94
ROC(12)
Downtrend And Accelerating -14.91
WillR(14)
Neutral -77.84
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
